650 related articles for article (PubMed ID: 30864716)
1. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
Li X; Xu W
Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
4. Survival of the fittest: Cancer challenges T cell metabolism.
Franchina DG; He F; Brenner D
Cancer Lett; 2018 Jan; 412():216-223. PubMed ID: 29074426
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
6. Immune metabolism in PD-1 blockade-based cancer immunotherapy.
Kumar A; Chamoto K
Int Immunol; 2021 Jan; 33(1):17-26. PubMed ID: 32622347
[TBL] [Abstract][Full Text] [Related]
7. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
8. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism.
De Rosa V; Di Rella F; Di Giacomo A; Matarese G
Cytokine Growth Factor Rev; 2017 Jun; 35():15-25. PubMed ID: 28442214
[TBL] [Abstract][Full Text] [Related]
10. T-cell immunometabolism against cancer.
Jiang S; Yan W
Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
[TBL] [Abstract][Full Text] [Related]
11. Emerging concepts of T cell metabolism as a target of immunotherapy.
Chang CH; Pearce EL
Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
[TBL] [Abstract][Full Text] [Related]
12. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
Rivadeneira DB; Delgoffe GM
Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
[TBL] [Abstract][Full Text] [Related]
13. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
Front Immunol; 2021; 12():645242. PubMed ID: 33815400
[TBL] [Abstract][Full Text] [Related]
14. Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries.
Ho PC; Kaech SM
Curr Opin Immunol; 2017 Jun; 46():38-44. PubMed ID: 28458087
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Barriers to T Cell Function in Tumors.
Sugiura A; Rathmell JC
J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
[TBL] [Abstract][Full Text] [Related]
16. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
Susek KH; Karvouni M; Alici E; Lundqvist A
Front Immunol; 2018; 9():2159. PubMed ID: 30319622
[TBL] [Abstract][Full Text] [Related]
17. Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability.
Bahrambeigi S; Sanajou D; Shafiei-Irannejad V
Immunol Lett; 2019 Aug; 212():81-87. PubMed ID: 31260743
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer.
Rogers T; DeBerardinis RJ
Trends Cancer; 2021 Aug; 7(8):700-713. PubMed ID: 34023325
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
20. The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?
Kareva I; Hahnfeldt P
Cancer Res; 2013 May; 73(9):2737-42. PubMed ID: 23423980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
